Top Key Companies for Syndromic Testing Market: Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics, Veramarx, Visby Medical, XCR Diagnostics, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc, Bosch Healthcare Solutions GmbH, Genetic Signatures, GenMark Dx (Roche), Hologic, Roche Molecular Diagnostics.
Global Syndromic Testing Market Size was estimated at USD 321.8 million in 2022 and is projected to reach USD 1382.44 million by 2028, exhibiting a CAGR of 27.5% during the forecast period.
Global Syndromic Testing Market Overview And Scope:
The Global Syndromic Testing Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Syndromic Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Syndromic Testing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Syndromic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Syndromic Testing market.
Global Syndromic Testing Market Segmentation
By Type, Syndromic Testing market has been segmented into:
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
By Application, Syndromic Testing market has been segmented into:
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
Regional Analysis of Syndromic Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Syndromic Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Syndromic Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Syndromic Testing market.
Top Key Companies Covered in Syndromic Testing market are:
Thermo Fisher Scientific Inc.
Qiagen
Abbott Diagnostics
Vela Diagnostics
Veramarx
Visby Medical
XCR Diagnostics
Beckman Coulter Diagnostics
Becton
Dickinson and Company
Bio-Rad Laboratories
Inc
Bosch Healthcare Solutions GmbH
Genetic Signatures
GenMark Dx (Roche)
Hologic
Roche Molecular Diagnostics
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Syndromic Testing Market by Type
5.1 Syndromic Testing Market Overview Snapshot and Growth Engine
5.2 Syndromic Testing Market Overview
5.3 Respiratory Infections
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Respiratory Infections: Geographic Segmentation
5.4 Sexually Transmitted Infections (STIs)
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Sexually Transmitted Infections (STIs): Geographic Segmentation
5.5 Gastrointestinal Infections
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Gastrointestinal Infections: Geographic Segmentation
5.6 Central Nervous System Infections
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Central Nervous System Infections: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Syndromic Testing Market by Application
6.1 Syndromic Testing Market Overview Snapshot and Growth Engine
6.2 Syndromic Testing Market Overview
6.3 Outbreak Response
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Outbreak Response: Geographic Segmentation
6.4 Emergency Departments
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Emergency Departments: Geographic Segmentation
6.5 Travel Medicine
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Travel Medicine: Geographic Segmentation
6.6 Military Medicine
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2026-2035F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Military Medicine: Geographic Segmentation
6.7 Public Health Surveillance
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2026-2035F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Public Health Surveillance: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Syndromic Testing Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Syndromic Testing Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Syndromic Testing Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 THERMO FISHER SCIENTIFIC INC.
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 QIAGEN
7.4 ABBOTT DIAGNOSTICS
7.5 VELA DIAGNOSTICS
7.6 VERAMARX
7.7 VISBY MEDICAL
7.8 XCR DIAGNOSTICS
7.9 BECKMAN COULTER DIAGNOSTICS
7.10 BECTON
7.11 DICKINSON AND COMPANY
7.12 BIO-RAD LABORATORIES
7.13 INC
7.14 BOSCH HEALTHCARE SOLUTIONS GMBH
7.15 GENETIC SIGNATURES
7.16 GENMARK DX (ROCHE)
7.17 HOLOGIC
7.18 ROCHE MOLECULAR DIAGNOSTICS
Chapter 8: Global Syndromic Testing Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Respiratory Infections
8.2.2 Sexually Transmitted Infections (STIs)
8.2.3 Gastrointestinal Infections
8.2.4 Central Nervous System Infections
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Outbreak Response
8.3.2 Emergency Departments
8.3.3 Travel Medicine
8.3.4 Military Medicine
8.3.5 Public Health Surveillance
Chapter 9: North America Syndromic Testing Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Respiratory Infections
9.4.2 Sexually Transmitted Infections (STIs)
9.4.3 Gastrointestinal Infections
9.4.4 Central Nervous System Infections
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Outbreak Response
9.5.2 Emergency Departments
9.5.3 Travel Medicine
9.5.4 Military Medicine
9.5.5 Public Health Surveillance
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Syndromic Testing Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Respiratory Infections
10.4.2 Sexually Transmitted Infections (STIs)
10.4.3 Gastrointestinal Infections
10.4.4 Central Nervous System Infections
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Outbreak Response
10.5.2 Emergency Departments
10.5.3 Travel Medicine
10.5.4 Military Medicine
10.5.5 Public Health Surveillance
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Syndromic Testing Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Respiratory Infections
11.4.2 Sexually Transmitted Infections (STIs)
11.4.3 Gastrointestinal Infections
11.4.4 Central Nervous System Infections
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Outbreak Response
11.5.2 Emergency Departments
11.5.3 Travel Medicine
11.5.4 Military Medicine
11.5.5 Public Health Surveillance
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Syndromic Testing Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Respiratory Infections
12.4.2 Sexually Transmitted Infections (STIs)
12.4.3 Gastrointestinal Infections
12.4.4 Central Nervous System Infections
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Outbreak Response
12.5.2 Emergency Departments
12.5.3 Travel Medicine
12.5.4 Military Medicine
12.5.5 Public Health Surveillance
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Syndromic Testing Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Respiratory Infections
13.4.2 Sexually Transmitted Infections (STIs)
13.4.3 Gastrointestinal Infections
13.4.4 Central Nervous System Infections
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Outbreak Response
13.5.2 Emergency Departments
13.5.3 Travel Medicine
13.5.4 Military Medicine
13.5.5 Public Health Surveillance
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Syndromic Testing Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Respiratory Infections
14.4.2 Sexually Transmitted Infections (STIs)
14.4.3 Gastrointestinal Infections
14.4.4 Central Nervous System Infections
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Outbreak Response
14.5.2 Emergency Departments
14.5.3 Travel Medicine
14.5.4 Military Medicine
14.5.5 Public Health Surveillance
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Syndromic Testing Scope:
|
Report Data
|
Syndromic Testing Market
|
|
Syndromic Testing Market Size in 2025
|
USD XX million
|
|
Syndromic Testing CAGR 2025 - 2032
|
XX%
|
|
Syndromic Testing Base Year
|
2024
|
|
Syndromic Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific Inc., Qiagen, Abbott Diagnostics, Vela Diagnostics, Veramarx, Visby Medical, XCR Diagnostics, Beckman Coulter Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc, Bosch Healthcare Solutions GmbH, Genetic Signatures, GenMark Dx (Roche), Hologic, Roche Molecular Diagnostics.
|
|
Key Segments
|
By Type
Respiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Central Nervous System Infections
Others
By Applications
Outbreak Response
Emergency Departments
Travel Medicine
Military Medicine
Public Health Surveillance
|
